Lower-cost generic drugs can save patients millions in medication costs, but only if they make it to pharmacy shelves.
What you don’t know about how drugs are tested and marketed could hurt you, says author Ben Goldacre in his book Bad Pharma
Two cases could trigger dramatic changes in the way medications and therapies are regulated.
Psychiatry — and medicine in general — has a dangerously close relationship with the pharmaceutical industry
The AIDS advocacy group Act-Up sped up the FDA’s drug approval process, improved patients’ access to drugs and changed the course of an epidemic. How did they do it?
In a new book, “Bad Pharma,” British columnist Dr. Ben Goldacre lays out all the clever ways in which the pharmaceutical industry is getting bad drugs onto shelves
Multibillion-dollar settlements against big drug companies have become all too common in recent years. Here’s a rogues gallery of the worst offenders
Why the Congressman’s recent diagnosis of bipolar 2 has a history of controversy
A Q&A with the author of Pharmageddon about how the pharmaceutical industry has co-opted medicine.
A proposed new definition of depression would include normal bereavement. Why that’s a bad idea.
In a sweeping investigation of doctors paid by leading pharmaceutical companies to promote their drugs, the nonprofit ProPublica has found that hundreds have been accused of professional misconduct, lacked credentials or have …
Welcome to Mind Reading, Healthland’s new series of talks with authors of “brainy” books.